Ahmed A. Ashour

598 total citations
18 papers, 433 citations indexed

About

Ahmed A. Ashour is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Ahmed A. Ashour has authored 18 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Epidemiology. Recurrent topics in Ahmed A. Ashour's work include Drug-Induced Hepatotoxicity and Protection (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cell Adhesion Molecules Research (3 papers). Ahmed A. Ashour is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cell Adhesion Molecules Research (3 papers). Ahmed A. Ashour collaborates with scholars based in Egypt, United States and Türkiye. Ahmed A. Ashour's co-authors include Bülent Özpolat, Nermin Kahraman, Zühal Hamurcu, Abdel‐Aziz H. Abdel‐Aziz, S. Neslihan Alpay, Longfei Huo, Nilgün Gürbüz, Ahmed M. Mansour, Tamer M. Abdelghany and Salama A. Salama and has published in prestigious journals such as Cancer Research, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Ahmed A. Ashour

17 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed A. Ashour Egypt 10 296 86 72 45 44 18 433
Ji Eon Park South Korea 13 281 0.9× 100 1.2× 75 1.0× 49 1.1× 31 0.7× 33 425
Siriporn Keeratichamroen Thailand 13 268 0.9× 89 1.0× 119 1.7× 59 1.3× 44 1.0× 23 492
AmirReza Hesari Iran 13 315 1.1× 163 1.9× 92 1.3× 42 0.9× 31 0.7× 17 530
Jiapeng Xu China 11 279 0.9× 135 1.6× 64 0.9× 60 1.3× 48 1.1× 24 438
Graziella Malaponte Italy 9 241 0.8× 67 0.8× 125 1.7× 35 0.8× 45 1.0× 10 481
Weili Min China 17 299 1.0× 110 1.3× 132 1.8× 63 1.4× 41 0.9× 26 591
Zhan‐Qi Cao China 10 275 0.9× 104 1.2× 112 1.6× 45 1.0× 42 1.0× 14 528
Shafquat Azim United States 12 275 0.9× 126 1.5× 153 2.1× 42 0.9× 52 1.2× 25 554
Yingchun He China 11 296 1.0× 149 1.7× 76 1.1× 44 1.0× 38 0.9× 35 493

Countries citing papers authored by Ahmed A. Ashour

Since Specialization
Citations

This map shows the geographic impact of Ahmed A. Ashour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed A. Ashour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed A. Ashour more than expected).

Fields of papers citing papers by Ahmed A. Ashour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed A. Ashour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed A. Ashour. The network helps show where Ahmed A. Ashour may publish in the future.

Co-authorship network of co-authors of Ahmed A. Ashour

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed A. Ashour. A scholar is included among the top collaborators of Ahmed A. Ashour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed A. Ashour. Ahmed A. Ashour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Karakaş, Didem, Ahmed A. Ashour, Hamada A. Mokhlis, et al.. (2025). eEF2K is a poor prognostic factor and novel molecular target in pancreatic cancer: regulating tumor growth and progression via the tumor microenvironment. Cell Death and Disease. 16(1). 501–501.
2.
Abdel‐Reheim, Mustafa Ahmed, et al.. (2024). Quillaja saponin mitigates methotrexate-provoked renal injury; insight into Nrf-2/Keap-1 pathway modulation with suppression of oxidative stress and inflammation. Journal of Pharmaceutical Health Care and Sciences. 10(1). 17–17. 3 indexed citations
3.
Mansour, Ahmed M., et al.. (2023). Estrogen/estrogen receptor activation protects against DEN-induced liver fibrosis in female rats via modulating TLR-4/NF-kβ signaling. European Journal of Pharmacology. 960. 176165–176165. 8 indexed citations
4.
Ashour, Ahmed A., et al.. (2022). The potential role of febrile condition in reversing the hepatoprotective effects of quercetin in the livers of LPS-presensitized mice. Life Sciences. 302. 120647–120647. 4 indexed citations
5.
Abdel‐Reheim, Mustafa Ahmed, et al.. (2022). Quillaja saponaria bark saponin attenuates methotrexate induced hepatic oxidative stress, inflammation and associated liver injury in rats. Journal of Applied Pharmaceutical Science. 4 indexed citations
6.
Erdoğan, Mümin Alper, et al.. (2022). SCN5A promotes the growth and lung metastasis of triple-negative breast cancer through EF2-kinase signaling. Life Sciences. 313. 121282–121282. 3 indexed citations
7.
Erdoğan, Mümin Alper, Ahmed A. Ashour, Erkan Yuca, Kıvanç Görgülü, & Bülent Özpolat. (2021). Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer. Cellular Signalling. 81. 109938–109938. 16 indexed citations
8.
9.
10.
Salah, Mostafa M., Ahmed A. Ashour, Tamer M. Abdelghany, Abdel‐Aziz H. Abdel‐Aziz, & Salama A. Salama. (2019). Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice. Life Sciences. 239. 116982–116982. 32 indexed citations
11.
Mokhlis, Hamada A., Recep Bayraktar, Nashwa Kabil, et al.. (2018). The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven Cancers. Molecular Therapy — Nucleic Acids. 14. 301–317. 28 indexed citations
12.
Hamurcu, Zühal, Nermin Kahraman, Ahmed A. Ashour, & Bülent Özpolat. (2017). FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer. Breast Cancer Research and Treatment. 163(3). 485–493. 34 indexed citations
13.
Gürbüz, Nilgün, et al.. (2016). A selective serotonin 5-HT1B receptor inhibition suppresses cells proliferation and induces apoptosis in human uterine leiomyoma cells. European Journal of Obstetrics & Gynecology and Reproductive Biology. 206. 114–119. 12 indexed citations
14.
El-Lakkany, Naglaa M., et al.. (2016). Bioavailability of paracetamol with/without caffeine in Egyptian patients with hepatitis C virus. European Journal of Clinical Pharmacology. 72(5). 573–582. 2 indexed citations
15.
Hamurcu, Zühal, Ahmed A. Ashour, Nermin Kahraman, & Bülent Özpolat. (2016). FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells. Oncotarget. 7(13). 16619–16635. 93 indexed citations
16.
Zhu, Qinchang, et al.. (2016). Biological Activities of Extracts from Different Parts of Cryptomeria japonica. Natural Product Communications. 11(9). 1337–1342. 14 indexed citations
17.
Ashour, Ahmed A., Nilgün Gürbüz, S. Neslihan Alpay, et al.. (2014). Elongation factor‐2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial–mesenchymal transition mediating pancreatic cancer cells invasion. Journal of Cellular and Molecular Medicine. 18(11). 2235–2251. 67 indexed citations
18.
Ashour, Ahmed A., Abdel‐Aziz H. Abdel‐Aziz, Ahmed M. Mansour, et al.. (2013). Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells. APOPTOSIS. 19(1). 241–258. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji Eon Park Breakdown of academic impact, for papers by Siriporn Keeratichamroen Breakdown of academic impact, for papers by AmirReza Hesari Breakdown of academic impact, for papers by Jiapeng Xu Breakdown of academic impact, for papers by Graziella Malaponte Breakdown of academic impact, for papers by Weili Min Breakdown of academic impact, for papers by Zhan‐Qi Cao Breakdown of academic impact, for papers by Shafquat Azim Breakdown of academic impact, for papers by Yingchun He
Rankless by CCL
2026